Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized drug repurposing in advanced thyroid cancer
NL-OMON61323Phase 1Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, single-arm trial in thyroid cancer, sponsored by Radboud University Medical Center. Planned start Jun 2026; status: not yet recruiting.
02
Conditions
thyroid cancer
Beyond the preview
Go deeper on NL-OMON61323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61323.